Aetion and Cegedim Health to Continue Rewarding RWD Partnership to Track Medication Efficacy and Safety

Aetion and Cegedim Health have announced that they will continue their real world data (RWD) partnership. The collaboration combines Aetion’s evidence platform with Cegedim’s RWD to evaluate medication efficacy and safety, as well as to understand the effects of COVID-19.

Cegedim Health’s Gilles Paubert remarks, “The COVID-19 pandemic has highlighted the relevance of real-world patient data and has changed health sector attitudes on the importance of recent, regularly updated data to help monitor patient symptom trends, as well as the safety and efficacy of new treatments for the benefit of public health.” Read more here.

(Source: Lucy Parsons, PharmaTimes, 7/13/21)